Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Saved in:
| Title: | Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. |
|---|---|
| Authors: | Wines BD; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia., Kurtovic L; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Trist HM; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia., Esparon S; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia., Lopez E; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Chappin K; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia., Chan LJ; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Mordant FL; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Lee WS; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Gherardin NA; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Patel SK; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia., Hartley GE; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Pymm P; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Cooney JP; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Beeson JG; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Department of Microbiology, Monash University, Clayton VIC, Australia., Godfrey DI; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Burrell LM; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia., van Zelm MC; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Alfred Hospital, Melbourne, VIC, Australia., Wheatley AK; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia., Chung AW; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Tham WH; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Subbarao K; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Kent SJ; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia., Hogarth PM; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Jul 28; Vol. 13, pp. 889372. Date of Electronic Publication: 2022 Jul 28 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35967361 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wines+BD%22">Wines BD</searchLink>; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kurtovic+L%22">Kurtovic L</searchLink>; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Trist+HM%22">Trist HM</searchLink>; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Esparon+S%22">Esparon S</searchLink>; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lopez+E%22">Lopez E</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chappin+K%22">Chappin K</searchLink>; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chan+LJ%22">Chan LJ</searchLink>; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mordant+FL%22">Mordant FL</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+WS%22">Lee WS</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gherardin+NA%22">Gherardin NA</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Patel+SK%22">Patel SK</searchLink>; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hartley+GE%22">Hartley GE</searchLink>; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Pymm+P%22">Pymm P</searchLink>; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Cooney+JP%22">Cooney JP</searchLink>; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Beeson+JG%22">Beeson JG</searchLink>; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Department of Microbiology, Monash University, Clayton VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Godfrey+DI%22">Godfrey DI</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Burrell+LM%22">Burrell LM</searchLink>; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22van+Zelm+MC%22">van Zelm MC</searchLink>; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Alfred Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Wheatley+AK%22">Wheatley AK</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chung+AW%22">Chung AW</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Tham+WH%22">Tham WH</searchLink>; Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Subbarao+K%22">Subbarao K</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kent+SJ%22">Kent SJ</searchLink>; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hogarth+PM%22">Hogarth PM</searchLink>; Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Jul 28; Vol. 13, pp. 889372. <i>Date of Electronic Publication: </i>2022 Jul 28 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35967361 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.889372 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 889372 Titles: – TitleFull: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wines BD – PersonEntity: Name: NameFull: Kurtovic L – PersonEntity: Name: NameFull: Trist HM – PersonEntity: Name: NameFull: Esparon S – PersonEntity: Name: NameFull: Lopez E – PersonEntity: Name: NameFull: Chappin K – PersonEntity: Name: NameFull: Chan LJ – PersonEntity: Name: NameFull: Mordant FL – PersonEntity: Name: NameFull: Lee WS – PersonEntity: Name: NameFull: Gherardin NA – PersonEntity: Name: NameFull: Patel SK – PersonEntity: Name: NameFull: Hartley GE – PersonEntity: Name: NameFull: Pymm P – PersonEntity: Name: NameFull: Cooney JP – PersonEntity: Name: NameFull: Beeson JG – PersonEntity: Name: NameFull: Godfrey DI – PersonEntity: Name: NameFull: Burrell LM – PersonEntity: Name: NameFull: van Zelm MC – PersonEntity: Name: NameFull: Wheatley AK – PersonEntity: Name: NameFull: Chung AW – PersonEntity: Name: NameFull: Tham WH – PersonEntity: Name: NameFull: Subbarao K – PersonEntity: Name: NameFull: Kent SJ – PersonEntity: Name: NameFull: Hogarth PM IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 07 Text: 2022 Jul 28 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
